Experience in the management of cornual ectopic pregnancy
DOI:
https://doi.org/10.31403/rpgo.v70i2601Keywords:
Pregnancy, ectopic, cornual, MethotrexateAbstract
Background: Cornual ectopic pregnancy accounts for 2%-4% of ectopic pregnancies
and is potentially fatal due to uterine rupture and consequent massive hemorrhage,
with a mortality rate of up to 2.5%. There is no consensus on the most appropriate
management of this pathology. Objective: To describe the experience in the
management of cornual ectopic pregnancy at the Instituto Nacional Materno
Perinatal, Lima, Peru. Methods: Descriptive and retrospective study of patients with
a diagnosis of cornual ectopic pregnancy during the year 2022. Data were obtained
from medical records. Statistical analysis was processed in the SPSS 19 program.
Results: Out of 9 cases of cornual ectopic pregnancy registered, 7 met the inclusion
criteria. The mean age was 31 years and the mean gestational age 7.3 weeks. Of the
cases 71.4% had no risk factors. The majority presented vaginal bleeding associated
with pelvic pain (71.4%). The average initial value of β-hCG was 8,262.3 mIU/mL. The
average size of the tumor was 36.7 mm and 28.6% of the cases presented uterine
rupture. 57.1% had surgical treatment consisting of cornual resection, cornuostomy
or local injection of methotrexate. Conclusions: Surgery is the most commonly used
treatment for cornual ectopic pregnancy. In recent years, laparoscopy has become
an important surgical option with certain advantages over laparotomy.
Downloads
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Alan Francis Miranda Flores
This work is licensed under a Creative Commons Attribution 4.0 International License.
Esta revista provee acceso libre inmediato a su contenido bajo el principio de que hacer disponible gratuitamente la investigación al publico, lo cual fomenta un mayor intercambio de conocimiento global.